bDMARDs Prevent ESRD in Most Patients With AA Amyloidosis

bDMARD therapy preserved renal function in 75% of patients with AA amyloidosis, but the remaining 25% progressed to ESRD despite receiving bDMARD therapy.
Medscape Medical News

source https://www.medscape.com/viewarticle/bdmards-preserve-renal-function-most-patients-aa-amyloidosis-2024a10008yz?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?